PRINCIPAL FINANCIAL GROUP INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1126328
DES MOINES, IA
Position in SUPN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$17,632,337
+$1,428,199 QoQ
Shares Held
341,117
+4.6% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $470,953,958 across 26 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
552,331 | $65,291,046 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
101,692 | $60,301,321 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
1,295,028 | $42,826,575 | |
| 4 | ALKS |
Alkermes plc.
|
958,016 | $33,875,445 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,386,907 | $33,188,684 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
238,161 | $31,375,329 | |
| 7 | HLN |
Haleon plc
|
2,803,530 | $28,063,335 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,282,266 | $26,619,841 |
All Filings in SUPN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,632,337 | 341,117 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $16,204,138 | 326,039 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $14,499,868 | 303,408 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $9,633,488 | 305,631 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $10,032,045 | 306,322 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $10,729,828 | 296,732 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $8,899,114 | 285,411 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $7,245,103 | 270,845 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $9,687,102 | 283,996 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $8,694,820 | 300,443 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $8,375,213 | 303,780 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $9,546,935 | 317,596 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $12,116,435 | 334,431 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $12,114,815 | 339,636 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $11,605,810 | 342,860 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $10,596,027 | 366,391 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $12,759,806 | 394,796 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $12,137,966 | 416,254 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $12,117,674 | 454,356 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $13,966,744 | 453,613 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $10,667,387 | 423,982 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $7,894,004 | 378,791 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $9,369,446 | 394,503 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $7,170,112 | 398,561 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||